Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Delta International Services & Logistics is a private healthcare company focused on the international development, distribution, training, and support of Scrambler Therapy Technology, a non-invasive electro-analgesia medical device platform for pain treatment. Its core commercial products are the Scrambler Therapy ST-5A system and the earlier MC-5A generation, which are positioned for chronic neuropathic and oncologic pain, particularly pain refractory to opioids and other treatments. The company appears to operate as the authorized international commercialization and support organization for the technology, providing distributor agreements, maintenance, and method-usage training rather than running a broad therapeutic drug pipeline. It has an Italian base and a U.S. operating presence through Delta International Services & Logistics (USA), Inc., doing business as Erickson Strong Medical. Overall, this is a health-related commercial-stage medical device and services company rather than a traditional biotech or pharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Delta International Services & Logistics.